Oncocyte PEG Ratio

Oncocyte (OCX) currently reports a PEG ratio of -12.5. That is below the Technology sector average of 13.11. Use the charts on this page to explore Oncocyte's PEG ratio history and peer comparisons.

Oncocyte's PEG ratio of -12.5 is lower than the Technology sector average of 13.11. That is roughly 195.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Oncocyte's market price to a fundamental measure such as earnings, sales, or book value. At -12.5, OCX can look expensive or cheap only in context — versus its own history, growth rate, and Technology peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of -12.5, then check the historical chart for trend and the peer comparison chart for relative positioning. The Technology average is 13.11. From there, open related valuation or income-statement pages for Oncocyte, and consider following OCX for alerts when major investors trade the stock.

Oncocyte is classified in the Technology sector. On PEG ratio, it currently shows -12.5 versus a sector average near 13.11. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing OCX with unrelated industries.